Therapeutic pipeline in nonalcoholic steatohepatitis | Nature Reviews Gastroenterology & Hepatology
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
Development of new drugs for the treatment of nonalcoholic steatohepatitis - Tang - 2020 - Journal of Digestive Diseases - Wiley Online Library
Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis - JHEP Reports
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
Key targets for drugs in phase 2 and phase 3 clinical trials. | Download Scientific Diagram
Aramchol - Wikipedia
Frontiers | Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments | Pharmacology
Drug discovery and treatment paradigms in nonalcoholic steatohepatitis - Noureddin - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial | Nature Medicine
Aramchol attenuated lipid accumulation and ROS production in... | Download Scientific Diagram
A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR) | Clinical Research Trial Listing ( Nonalcoholic Steatohepatitis (NASH) ) ( NCT04104321 )
Galmed Pharmaceuticals: Strong Fundamentals Powering A NASH Innovator (NASDAQ:GLMD) | Seeking Alpha
One-year results of the Global Phase 2b randomized placebo-controlled ARREST Trial of Aramchol, a Stearoyl CoA Desaturasemodulator in NASH patients
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial | Nature Medicine
The Armor Study - Armor
IJERPH | Free Full-Text | Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives | HTML
Frontiers | Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments | Pharmacology
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease - Clinical Gastroenterology and Hepatology
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
FDA Agrees with Galmed's Plan to use Aramchol Meglumine in the Randomized Double-Blind Placebo-Controlled Part of the Phase 3 ARMOR study
One-year results of the Global Phase 2b randomized placebo-controlled ARREST Trial of Aramchol, a Stearoyl CoA Desaturasemodulator in NASH patients
Aramchol™ reduces fibrosis progression in 24 weeks
